Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

Share Price is delayed by 15 minutes
Get Live Data
123.50    1.00 (0.82%)
Bid:
123.00
Ask:
125.00
Spread: 2.00 (1.626%)
Market Cap: £196.76m
RCN Live PriceLast checked at - London Stock Exchange

Intraday Redcentric Share Chart

Director/PDMR Shareholding

6 Dec 2023 07:00

RNS Number : 7840V
Redcentric PLC
06 December 2023
 

Redcentric plc

Director/PDMR Shareholdings

Redcentric plc (AIM:RCN) "Redcentric" or the "Company") a leading UK IT managed services provider, received notification from Kestrel Partners LLP ("Kestrel") that on 1 December 2023 it purchased, on behalf of its discretionary client accounts, an aggregate of 150,000 ordinary shares of 0.1 pence each ("Ordinary Shares") in the Company at an average price of £1.245 per Ordinary Share.

Mr Oliver Scott is a partner of, and holds a beneficial interest in, Kestrel. Mr Scott is also a shareholder in Kestrel Opportunities and is therefore deemed to have a beneficial interest in Kestrel Opportunities' entire legal holding in Redcentric.

Following this transaction, Kestrel Opportunities holds (and consequently Mr Scott is deemed to have a beneficial interest in) 16,402,618 Ordinary Shares in the Company, and other clients of Kestrel, in which Mr Scott has no beneficial interest, hold 15,327,776 Ordinary Shares in the Company.

On a combined basis, Kestrel indirectly holds voting rights over 31,730,394 Ordinary Shares in the Company, which represents approximately 20.30 per cent of the total voting rights in the Company.

Kestrel's interest in the Shares in the Company is held through the following nominees:

Holding type

Nominee

No. of Ordinary Shares

% of total voting rights

Indirect

Bank of New York Nominees Ltd

16,402,618

10.49%

Indirect

JIM Nominees Limited

464,310

0.30%

Indirect

Bank of New York Nominees Ltd

12,238,465

7.83%

Indirect

Northern Trust Company AVFC

2,625,001

1.68%

 

For further information contact:

 

Redcentric plc

Peter Brotherton, Chief Executive Officer

David Senior, Chief Financial Officer

 +44 (0) 800 983 2522

 

 

Cavendish Capital Markets Limited (NOMAD and Sole Broker)

Marc Milmo / Simon Hicks / Charlie Beeson (Corporate Finance)

Andrew Burdis / Sunila de Silva (ECM)

 

+44 (0) 20 7220 0500

 

 

 

 

 

 

ANNEX

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Kestrel Partners LLP

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PCA - Oliver Scott (non-executive director Redcentric plc)

b)

 

Initial notification /Amendment

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Redcentric plc

b)

 

LEI

 

213800FGYMMNE9OKFD14

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Identification code

 

0.1 pence Ordinary Shares

 

 

ISIN: GB00B7TW1V39

b)

 

Nature of the transaction

 

 Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

 

Transfer

 

Purchase

 

Price(s)

Volume(s)

£1.245

150,000

d)

 

Aggregated information

- Aggregated volume

- Price

 

Purchase Total 150,000 Ordinary Shares at a price of £1.245

e)

 

Date of the transaction

 

1 December 2023

f)

 

Place of the transaction

London AIM

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHTABPTMTBMBBJ
Date   Source Headline
23rd Nov 20237:00 amRNSDirector/PDMR Shareholding
22nd Nov 20237:00 amRNSDirectorate Change
22nd Nov 20237:00 amRNSHalf Year Results
20th Oct 20231:23 pmRNSHolding(s) in Company
3rd Oct 20237:00 amRNSExercise of Options
3rd Oct 20237:00 amRNSSave As You Earn Share Option Scheme
28th Sep 20234:00 pmRNSResult of AGM
20th Sep 20234:08 pmRNSGrant of Options and Director/PDMR Shareholding
4th Sep 20237:00 amRNSPublication of Annual Report and Notice of AGM
24th Aug 20237:00 amRNSPreliminary results announcement FY23
17th Aug 20237:00 amRNSNotice of Results
17th Jul 20237:00 amRNSUpdate on Annual Results
28th Apr 20235:08 pmRNSHolding(s) in Company
25th Apr 20237:01 amRNSDirectorate Change
25th Apr 20237:00 amRNSTrading Update
31st Mar 20233:14 pmRNSHolding(s) in Company
22nd Feb 20237:00 amRNSExercise of Options
8th Feb 20237:00 amRNSExercise of Options
11th Jan 20237:00 amRNSExercise of Options
30th Dec 20227:00 amRNSExercise of Options
12th Dec 20227:00 amRNSExercise of Options
8th Dec 20227:00 amRNSHalf Year Results
29th Nov 20223:09 pmRNSHolding(s) in Company
17th Nov 20222:46 pmRNSHolding(s) in Company
15th Nov 20227:00 amRNSTrading Update
2nd Nov 20227:00 amRNSExercise of Options
26th Oct 20227:00 amRNSExercise of Options
19th Oct 20227:00 amRNSExercise of Options
13th Oct 20222:06 pmRNSHolding(s) in Company
13th Oct 20227:00 amRNSGrant of Options and Director/PDMR Shareholding
5th Oct 202210:57 amRNSHolding(s) in Company
5th Oct 20227:00 amRNSExercise of Options
16th Sep 202212:36 pmRNSHolding(s) in Company
15th Sep 202212:54 pmRNSHolding(s) in Company
15th Sep 202212:25 pmRNSExercise of Options and PDMR Shareholding
14th Sep 20227:00 amRNSExercise of Options
13th Sep 202211:52 amRNSHolding(s) in Company
7th Sep 20224:28 pmRNSResult of AGM
6th Sep 20227:00 amRNSExercise of Options
5th Sep 20221:53 pmRNSHolding(s) in Company
30th Aug 20227:00 amRNSSave As You Earn Share Option Scheme
30th Aug 20227:00 amRNSExercise of Options
23rd Aug 20229:23 amRNSExercise of Options
17th Aug 20227:00 amRNSExercise of Options
8th Aug 20227:00 amRNSPublication of Annual Report and Notice of AGM
1st Aug 202212:10 pmRNSHolding(s) in Company
1st Aug 20227:00 amRNSExercise of Options
22nd Jul 202212:08 pmRNSHolding(s) in Company
21st Jul 20227:01 amRNSAlan Aubrey - AIM Rule 17 Disclosures
21st Jul 20227:00 amRNSPreliminary results announcement FY22

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.